Uterine Fibroids treatment in Newport Beach

Uterine Fibroids treatment in Newport Beach

DR. BRUCE LEE FEATURED ON “THE DOCTORS”
OB-GYN Dr. Bruce Lee, creator of the Acessa procedure, explains that the new surgical option involves creating just two small incisions in the abdomen, inserting a needle into the tumor and using radiofrequency energy to destroy it while leaving the uterus intact. The tumor is then reabsorbed into the surrounding tissue and is not likely to return. The procedure allows for a rapid recovery, compared to hysterectomy, a low rate of recurrence and minimal post-operative pain. Dr. Lee believes his procedure can reduce the number of unnecessary hysterectomies performed each year.
Michelle and Dr. Lee join The Doctors onstage, and Michelle says she’s feeling great after undergoing the procedure to remove nine fibroids.
Dr. Lee is a board certified gynecologist with twenty nine years of clinical and research experience. He is the inventor and world’s leading practitioner of Acessa, the safe, effective, Federal Drug Administration-approved alternative to hysterectomy and myomectomy.
He has helped establish two new Los Angeles-area medical centers dedicated exclusively to the life-changing treatment – the Center for Uterine Fibroid Treatment at Southern California Hospital at Culver City and Rox Fibroid Treatment Center at Roxbury Surgical Associates in Beverly Hills.
Known as the Acessa Procedure, Dr. Lee has since treated four thousand fibroid tumors in over 500 patients. In 2005, he cofounded Halt Medical, Inc which was created to design, develop, and manufacture new instrumentation specifically for the Acessa Procedure.
While Chief Medical Officer, he worked with a dedicated team of engineers to design the Halt Fibroid Ablation System, oversaw phase 2 and phase 3 clinical trials, designed and produced the Acessa teaching methodology and instruction materials, and authored multiple peer review articles.
Since 2008, he has instructed physicians in the performance of Acessa in Canada (Vancouver, Toronto, Regina), Germany (Tubingen), Mexico (Monterrey), Guatemala (Guatemala City) and in hospitals and universities in 13 U.S. states.